Stryker Co. (NYSE:SYK) Stock Position Lowered by Northstar Asset Management Inc.

Northstar Asset Management Inc. reduced its stake in Stryker Co. (NYSE:SYK - Free Report) by 3.6% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 49,912 shares of the medical technology company's stock after selling 1,862 shares during the quarter. Stryker accounts for approximately 4.7% of Northstar Asset Management Inc.'s portfolio, making the stock its 3rd largest holding. Northstar Asset Management Inc.'s holdings in Stryker were worth $17,971,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Dunhill Financial LLC boosted its stake in Stryker by 94.9% in the third quarter. Dunhill Financial LLC now owns 76 shares of the medical technology company's stock valued at $27,000 after acquiring an additional 37 shares during the last quarter. Darwin Wealth Management LLC bought a new stake in shares of Stryker in the 3rd quarter worth approximately $36,000. Activest Wealth Management purchased a new position in Stryker in the fourth quarter valued at approximately $36,000. Crews Bank & Trust bought a new position in Stryker during the fourth quarter valued at $39,000. Finally, Hara Capital LLC purchased a new stake in Stryker in the third quarter worth $42,000. Institutional investors own 77.09% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on SYK shares. Piper Sandler reaffirmed an "overweight" rating and set a $420.00 price target (up previously from $380.00) on shares of Stryker in a research report on Wednesday, October 30th. Citigroup upped their price objective on shares of Stryker from $411.00 to $450.00 and gave the company a "buy" rating in a report on Wednesday, December 11th. Robert W. Baird lifted their target price on shares of Stryker from $378.00 to $405.00 and gave the stock an "outperform" rating in a research note on Wednesday, October 30th. Wells Fargo & Company upped their price target on shares of Stryker from $427.00 to $435.00 and gave the company an "overweight" rating in a research note on Wednesday, January 29th. Finally, Needham & Company LLC reiterated a "buy" rating and issued a $442.00 price objective on shares of Stryker in a research note on Wednesday, January 29th. Five analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $420.68.

Insider Transactions at Stryker

In other Stryker news, Director Ronda E. Stryker sold 201,392 shares of the firm's stock in a transaction dated Friday, January 31st. The stock was sold at an average price of $392.24, for a total transaction of $78,993,998.08. Following the sale, the director now owns 3,642,075 shares in the company, valued at $1,428,567,498. This trade represents a 5.24 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Allan C. Golston sold 2,458 shares of the company's stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $383.07, for a total value of $941,586.06. Following the completion of the transaction, the director now owns 14,895 shares of the company's stock, valued at $5,705,827.65. The trade was a 14.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 5.90% of the stock is currently owned by insiders.

Stryker Price Performance

NYSE SYK traded down $3.82 during trading on Friday, reaching $382.59. The company's stock had a trading volume of 1,268,413 shares, compared to its average volume of 1,388,856. The firm has a fifty day moving average of $378.07 and a 200 day moving average of $368.67. Stryker Co. has a one year low of $314.93 and a one year high of $406.19. The stock has a market capitalization of $145.99 billion, a PE ratio of 49.30, a P/E/G ratio of 2.93 and a beta of 0.96. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32.

Stryker (NYSE:SYK - Get Free Report) last posted its quarterly earnings data on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share for the quarter, topping the consensus estimate of $3.87 by $0.14. Stryker had a net margin of 13.25% and a return on equity of 23.58%. During the same period in the previous year, the business earned $3.46 EPS. Analysts expect that Stryker Co. will post 13.49 EPS for the current fiscal year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 30th. Stockholders of record on Monday, March 31st will be given a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a dividend yield of 0.88%. The ex-dividend date is Monday, March 31st. Stryker's dividend payout ratio (DPR) is currently 43.30%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.